Eagle Pharmaceuticals
EGRX
#10391
Rank
A$9.7 M
Marketcap
A$0.75
Share price
-41.18%
Change (1 day)
-33.69%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$9.7 Million

As of January 2026 Eagle Pharmaceuticals has a market cap of A$9.7 Million. This makes Eagle Pharmaceuticals the world's 10391th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$9.7 M11.51%
2025A$8.7 M-24.02%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

End of Day market cap according to different sources

On Jan 18th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
A$16.5 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$789.38 B 8,130,895.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$146.02 B 1,504,038.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$414.99 B 4,274,534.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
A$54.59 B 562,286.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$266.59 B 2,745,945.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.394 T 14,367,308.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$168.56 B 1,736,182.37%๐Ÿ‡บ๐Ÿ‡ธ USA